Malaria is a global health concern and research efforts are ongoing to develop a superior vaccine 53 to RTS,S/AS01. To guide immunogen design, we seek a comprehensive understanding of the 54 protective humoral response against Plasmodium falciparum circumsporozoite protein (PfCSP). 55
Malaria is a vector-borne disease of global importance. In 2017, an estimated 219 million 71 cases were reported, resulting in 435,000 deaths (WHO, 2018) Murugan et al., 2019) . The few described mAbs to C-CSP were 94 functionally ineffective, probably, due to low accessibility of this domain on the sporozoite surface 95 (Scally et al., 2018) . In contrast, the functional relevance of N-CSP mAbs remains elusive. To 96 date, no human mAb specific for this domain and only a handful of murine mAbs from 97 immunization studies with recombinant Pf N-CSP have been reported (Espinosa et al., 2015; 98 Herrera et al., 2015) . These mAbs recognized N-CSP epitopes adjacent to Region I (RI; Fig. 1A) , 99 a site with high conservation across Plasmodium species, suggesting that RI may be a good target 100 for cross-species vaccine development (Dame et al, 1984; Espinosa et al., 2015) . Additionally, 101 proteolytic cleavage of RI was linked to efficient sporozoite invasion of host hepatocytes (Espinosa 102 et al., 2015; Coppi et al., 2005) . Based on these observations, it has been proposed that adding N-103 CSP, including the RI motif, into a PfCSP subunit vaccine may improve protective efficacy 104 compared to the current leading vaccine RTS,S/AS01, which lacks this domain. However, passive 105 transfer of the most potent RI-targeting mAb 5D5 protected mice from infection in only one of the 106 two tested transgenic rodent P. berghei (Pb) models that expressed a chimeric PbCSP with the Pf 107 N-CSP domain (Espinosa et al., 2015) , and its impact on Pf has not been determined. Thus, crucial 108 information on how mAb 5D5 binds and inhibits Pf sporozoites is still missing. 109
To gain a molecular understanding of how the mAb 5D5 recognizes PfCSP and inhibits Pf 110 sporozoite infectivity, we solved the crystal structure of the 5D5 Fab in complex with a peptide 111 derived from N-CSP and conducted in-depth binding and functional experiments with Pf 112 sporozoites. We specifically quantified reactivity of mAb 5D5 to single live Pf sporozoites isolated 113 from the midgut and salivary glands of mosquitoes using imaging flow cytometry, and tested its 114 inhibitory potency against Pf sporozoites through in vitro traversal assays and in vivo passive mAb 7 transfer experiments in mosquitoes. Our work provides a detailed molecular and functional 116 understanding of mAb 5D5 recognition of its epitope, and highlights poor recognition of this N-117 CSP epitope on the Pf sporozoite surface. 118
119
Results and Discussion 120 mAb 5D5 binds an α-helical motif in N-CSP 121
To understand the molecular basis for mAb 5D5 recognition of PfCSP, we solved the 122 crystal structure of the 5D5 Fab in complex with PfCSP81-98 to 1.85 Å resolution (Supplementary 123 Table 1 ). We specifically selected PfCSP residues 81-98 for our studies to ensure inclusion of the 124 mAb 5D5 epitope, identified as Pf N-CSP residues 82-91 by yeast display epitope mapping (Fig. 125 1A and S1A) in agreement with previous reports (Espinosa et al., 2015) , as well as conserved RI 126 residues KLKQP in positions 93-97. Consistent with our yeast display experiments, we observed 127 strong electron density for N-CSP residues 81-92 (EDNEKLRKPKHK) in the crystal structure 128 ( Fig. S1B ). PfCSP residues 83-91 formed an α-helix when bound by 5D5 Fab (Fig. 1B) , in line 129 with secondary structure predictions based on the primary sequence (Drozdetskiy et al., 2015) . chain. Furthermore, the mAb 5D5 CDRs possess extensive shape and electrostatic 161 complementarity to this highly charged N-CSP epitope (Fig. 1D ). An electropositive pocket 162 formed by HCDR2 contacts PfCSP residues D82 and E84 via H-bonds with Ser54 Oγ , Asn56 Nδ2 , 163 and Tyr58 OH , and water-mediated H-bonds with Arg53 N and Ser54 Oγ (Fig. 1E ). Additionally, an 164 electronegative pocket formed by HCDR2, HCDR3, KCDR1, and KCDR3 contacts PfCSP 165 electropositive residues R87, K90 and H91 via several H-bonds and salt bridges ( Fig. 2A ). The 166 significance of this shape and charge complementarity for high affinity binding was observed in 167 our yeast display experiments, as mutations maintaining both side chain length and electrostatic 168 properties, such as K90R, were more likely to sustain high affinity binding than those that did not 169 (K90E, K90D; Fig. 1A ). 170 Consistent with prediction from the primary mAb 5D5 sequence, we observed electron 171 density for two GlcNAc and one α1-6Fuc moieties indicative of N-linked glycosylation at Asn98 172 of HCDR3 ( Fig. 2A and S1C). Importantly, the first N-linked GlcNAc moiety contacts the 173 aliphatic portion of K90 of PfCSP81-98, conferring 48 Å 2 of BSA, while the other sugars did not 174 interact with the peptide. In this way, the paratope glycan contributes to mAb 5D5 occlusion of 175 PfCSP residue K90. Interestingly, K90 is one of four lysine residues (including K85, K88, and 176 K92) directly upstream of RI that have previously been proposed to be important for binding 
279
To evaluate the inhibitory activity of mAb 5D5 against Pf sporozoites in their natural 280 environment in vivo, we developed a passive mAb transfer assay for mosquitoes that examined 281 sporozoite maturation and salivary gland invasion. Mosquitoes were injected with recombinant 282 single-chain Fabs (scFabs) two days before Pf infection, and sporozoite loads in dissected salivary 283 glands were quantified two weeks later (Fig. 4E ). Injection of scFab1210 significantly reduced the 284 number of mature sporozoites in the salivary glands. In contrast, transfer of scFab1710 or 285 scFab5D5 did not affect sporozoite development and invasion (Fig. 4F ). Taken together, these 286 results demonstrate that mAb 5D5 fails to efficiently recognize its epitope on the surface of Pf 287 parasites, and lacks inhibitory potency against sporozoites in both the vector and the host. 
Materials and Methods 302

Mutant N-CSP yeast display library construction and transformation 303
Epitope mapping using phage display was adapted from a previously published method 304 (Van Blarcom et al., 2015) . Construction of the mutant library required generation of a linearized 305 vector and a library of mutant N-CSP inserts. The mutant insert library was generated by two 306 rounds of PCR using primers that carried the randomized codon "NNK" (Tables S2 and S3 ), and 307 mixing the products (Amplicons 1 to 9) at an equal molar ratio. The vector was generated by 308 overlapping PCR using vector-F/R primers (Table S2 ). All PCR products were amplified using 309 KOD DNA polymerase (EMD Millipore) and purified by gel extraction (Clontech Libraries). 310
The EBY100 yeast strain was purchased from ATCC. The yeast vector was generated by 311 modification of the commercially available pCTcon2 vector (Addgene; Chao et al., 2006 ). The 312 mutant N-CSP insert was cloned with N-terminal V5 and C-terminal HA epitope tags. The Aga2p 313 yeast protein gene was inserted downstream of the HA epitope tag to allow for yeast surface 314 display of the N-CSP (plasmid pCTcon2-rsCSP-V5-HA-Aga2p). Yeast transformation was 315 performed as described previously (Benatuil et al., 2010) . In summary, 4 µg of the linearized yeast 316 expression vector and 8 µg of the N-CSP mutant library insert were used for transformation. 317
Transformants were plated on SDCAA plates and incubated at 30°C for 2 days. Over 10 8 colonies 318
were collected, resuspended in YPD media with 15% glycerol, and stored at -80°C until use. 319 
5D5 Fab production and purification
Yeast display epitope mapping 364
For each sorting round, ~10 9 yeast cells from the frozen stock were cultured in 250 mL of 365 SDCAA media for 16 h at 27.5°C until an OD of 1.9 was reached. Cells were pelleted, resuspended 366 in 35 mL of SGR-CAA induction media and incubated for 30 h at 18°C until an OD of 1.4 was 367 reached. After harvesting approximately 8 mL of cell culture, the pellet was washed 3 times with 368 streptavidin at a molar ratio of 1:2 for 20 min. The biotinylated 5D5 IgG-streptavidin BB515 370 complex and Anti-HA PE antibody were added to the 5 mL of resuspended yeast cells with a final 371 concentration of 20 nM for each stain, followed by overnight incubation at 4°C with head-to-head 372 rotation in the dark. Next, cells were washed twice with PBS, resuspended in 5 mL of PBS, and 373 sorted at the TSRI Flow Cytometry Core Facility. Two gates were applied for simultaneous sorting 374 PfCSP71-104. Unrelated malaria protein Pfs25 was used to block non-specific binding and 5D5 IgG 415 was used as a positive control. PfCSP71-104, PfCSP or Pfs25 was diluted to 10 µg/mL in kinetics 416 buffer and immobilized onto Ni-NTA (NTA) biosensors (FortéBio). Once a stable baseline was 417 established, biosensors were dipped into wells, each containing a different IgG diluted to 500 nM 418 in kinetics buffer. Tips were subsequently dipped back into kinetics buffer to observe any 419 dissociation of IgG. 420
Mosquito rearing, parasite infections and sporozoite isolations 421
Anopheles coluzzii (Ngousso strain) mosquitoes were maintained at 29°C 70-80% 422 humidity 12/12 h day/night cycle. For P. falciparum infections, mosquitoes were fed for 15 min 423 on a membrane feeder with NF54 gametocytes cultured with O + human red blood cells (Haema,  424 Berlin), and, thereafter, kept in a secured S3 laboratory according to the national regulations 425 (Landesamt für Gesundheit und Soziales, project number 297/13). The P. falciparum NF54 clone 426 used in this study originated from Prof. Sauerwein's laboratory (RUMC, Nijmegen) and was 427 authenticated for Pfs47 genotype by PCR on genomic DNA. P. falciparum asexual cultures were 428 monthly tested for Mycoplasma contamination. Unfed mosquitoes were removed shortly after 429
infections. Blood fed mosquitoes were offered an additional uninfected blood meal eight days post 430 infection, maintained at 26°C for 12 and 14/15 days, and used for the midgut and salivary gland 431 dissections, respectively. The midgut or salivary gland sporozoites were isolated into HC-04 432 complete culture medium (MEM without L-glutamine (Gibco) supplemented with F-12 Nutrient
Imaging flow cytometry of sporozoites 436
Isolated sporozoites were diluted in PBS/1% FCS to 3x10 6 /mL and incubated for 30 min 437 at 4°C with 1 µg/mL recombinant IgGs, washed (16,000 x g, 4 min, 4°C) and incubated with Cy5-438 conjugated anti-human IgG1 (0.4 µg/ml, DRFZ Core Facility, Berlin) for 30 min at 4°C. After 439 incubation with the secondary antibody, sporozoites were further incubated with propidium iodide 440 (20 µg/mL, Sigma Aldrich) for 5 min at room temperature as previously described (Costa et al., 441 2018) . Sporozoites were acquired after one wash in PBS using the ImageStreamX Mk II instrument 442 (Merck Millipore) with a 60X objective for 15-20 min per sample. The experiments were 443 performed in three replicates. To avoid a possible bias due to the variable pre-acquisition waiting 444 times on ice, the order of samples was swapped between the experimental replicates. 445
Quantification of propidium iodide staining was performed using the Intensity_MC_Ch04, 446
whereas mAb binding was quantified by Cy5-conjugated secondary antibody signal 447
Intensity_MC_Ch11. Single sporozoites were manually selected by brightfield images (Channel 448 9) and only live, propidium iodide-negative sporozoites were gated for mAbs binding efficiency 449 analysis (for gating strategy see Fig. S2 ). The analysis was performed with IDEAS 6.2 (Merck 450 Millipore). Raw data were exported as .txt files and represented in dot and density plots using 451 RStudio Version 1.1.453. 452
Pf sporozoite hepatocyte traversal assay 453
Pf traversal assays were performed as previously described (Triller et al., 2017) . In brief, 454 the salivary gland sporozoites were isolated from mosquito thorax and treated with mAbs (100 455 diluted in PBS or with 285 µL PBS as an injection control. Two days later, mosquitoes were 466 infected with P. falciparum NF54 following the protocol described above. Mosquito heads were 467 carefully pulled off 14 days later and the attached salivary glands were collected and washed with 468 PBS. Dissected salivary glands were pooled for each group, homogenized and the freshly isolated 469 sporozoites were counted using a Malassez hemocytometer. The average number of sporozoites 470 per mosquito was calculated for each group. 471
Enzyme-linked immunosorbent assay 472
Antigen ELISA detHigh binding 384 well polystyrene plates (Corning) were coated with 473 recombinantly expressed PfCSP71-104 comprising N-CSP at 50 ng/well overnight at 4°C. 1% BSA 474 in PBS was used for blocking the wells at RT. Binding of mAbs to N-CSP was determined by 475 incubating the coated plates with serially diluted mAb at 4.00, 1.00, 0.25, 0.06 µg/mL 476 concentrations. Bound mAb was detected using goat anti-human IgG-HRP (Jackson 477 ImmunoResearch) at 1:1,000 dilution in 1% BSA in PBS and One-step ABTS substrate (Roche). 478
Statistical analysis 482
No samples were excluded from the analyses. Mosquitoes from the same batches were 483 randomly allocated to the experimental groups (age range: 1-2 days). The experimenters were not 484 blinded to the group allocation during the experiment and/or when assessing the outcome. Sample 485 sizes were chosen according to best practices in the field and previous experience (Costa et al., 486 2018) . The combined p-values from the z-test were much smaller than the total sample size, which is 500 roughly 10 4 . p-values much smaller than the inverse of the population size were therefore rounded 501 up to 10 -4 . 502 The null hypothesis was that the proportions of sporozoites bound by the tested mAbs were not 513 different. Normality was verified and a z-test was used to compare the fractions of mAb-bound 514 sporozoites. We first computed the fraction of mAb-bound for each mosquito tissue, experiment 515 and treatment as M = pos M tot M ⁄ . The fraction can be considered as the probability that a 516 sporozoite taken at random is bound by a certain mAb. The error associated to is therefore given 517 by ( ) = R (1 − )⁄ , where N is the sample size given in the column tot1. Within each 518 experiment, we used a two-sided z-test to test the null hypothesis that the fractions associated to 519 the tested mAbs were not different, resulting in six pairwise comparisons per experiment. The 520 resulting p-values from the three independent experiments were combined using Fisher method 521 and are summarized below with significant -values highlighted in green: 522 523 524 525 526 For both Figures 3D and 4D , the fractions organized from strong to weak are as follows: 1210, 527 5D5, 5D5Dg, 1710. The combined p-values computed with the Fisher method are much smaller 528 than the total sample size, which is roughly 10 4 . The reported p-values are therefore the inverse of 529 the total sample size. 530 The null hypothesis was that the average number of sporozoites for each scFab and for each 550 experiment independently was not significantly different. To perform this test, we used the number 551 of oocysts per mosquito from the same experiments (data available upon request). We have 552 assumed that the number of oocysts per mosquito follows a negative binomial distribution with 553 average oocyst number and shape parameter : 554 555 556 557
that gives the probability that the number of oocysts in one mosquito is equal to , for = 558 0, 1, 2, etc. We determined the two parameters and using a Bayesian approach with the 559 We then assumed that the number of sporozoites was linearly proportional to the number of oocysts 569 (Vaughan et al., 1992; Stone et al., 2013; Miura et al., 2019) . This allowed us to replace (as 570 derived from oocysts distribution) in the negative binomial with the average sporozoite number as 571 given above. We used the MLE estimate of the shape parameter and simulated 10,000 572 independent samples of mosquitoes of size given above. Each simulated sample is thus statistically 573 identical to those provided by the experimental data. 574
Metropolis
Finally, for each two treatments and for each pair of simulated samples, we tested the null 575 hypothesis that there is no difference between the treatments by random sampling while keeping 576 sample sizes as in the experimental data. We thus created a distribution of the difference between 577 the average number of sporozoites in the two treatments to be compared under this null 578 hypothesis. The comparison of this distribution with the difference in sporozoite numbers as 579 given by the experimental data produces the -value listed below. The combined p-value using 580 the Fisher method and true from false positives were discriminated using the Benjamini-581 Hochberg (BH) and the Benjamini-Liu (BL) methods at a false discovery rate = 10 kl . 582 To check the consistency of this method, we simulated the sampled mosquito populations but 590 skipped the shuffling across the samples. 591
(Online) Supplemental Material 593
Supplemental materials include three tables and three figures. Supplemental tables: X-ray 594 crystallography data collection and refinement (Table S1), description of primers used to generate 595 mutant insert library for yeast display (Table S2) , and PCR reactions and products for mutant insert 596 library construction (Table S3) 
